| Literature DB >> 27530158 |
Shumaila Jan1, Muhammad Rashid Khan2.
Abstract
BACKGROUND: Oxidative stress is believed to be a root cause of various degenerative and fibrotic disorders. Dietary foods enrich in antioxidants can cure or curtail the progression of oxidative stress induced disorders. Fruit of Monotheca buxifolia is used locally for digestive and urinary tract disorders. We have evaluated the protective potential of the methanol extract of M. buxifolia (MBM) in rat exposed to carbon tetrachloride (CCl4) toxicity.Entities:
Keywords: Antioxidant enzymes; DNA damages; Kidney; Lipid peroxidation; Monotheca buxifolia
Mesh:
Substances:
Year: 2016 PMID: 27530158 PMCID: PMC4988013 DOI: 10.1186/s12906-016-1256-0
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
LC50 for brine shrimp and LD50 for oral toxicity studies of MBM in rat
| Assays | Time | MBM |
|---|---|---|
| Brine Shrimp Lethality (LC50) | 06 h | No death |
| 12 h | 4.019 mg/ml | |
| 24 h | 1.354 mg/ml | |
| Acute Oral Toxicity (LD50) | 14 days | >4000 mg/kg |
Fig. 1Effect of MBM on brine shrimp lethality after 24 h of treatment
Polyphenolic content of methanol extract of M. buxifolia
| Phenolic compounds | Retention Time (min) | Concentration (μg/mg dry weight) |
|---|---|---|
| Gallic acid | 3.228 | 3.329 ± 0.006 |
| Catechin | 9.128 | 1.342 ± 0.004 |
| Caffeic acid | 11.303 | 1.263 ± 0.003 |
| Rutin | 14.757 | 6.417 ± 0.008 |
Values are expressed as mean ± SE (03)
Fig. 2a HPLC-DAD analysis of methanol extract of M. buxifolia. b Qualitative separation of different polyphenols by TLC, gallic acid (Rf: 0.21), caffiec acid (Rf: 0.37), rutin (Rf: 0.52) and catechin (Rf: 0.79)
Effect of M. buxifolia on physical properties of urine in rat
| Treatment mg/kg bw | pH | Specific gravity | RBC/HPF | Pus cells/HPF | Epithelial cells |
|---|---|---|---|---|---|
| Control | 7.04 ± 0.13a | 1.05 ± 0.08c | 1.06 ± 0.21d | 2.41 ± 0.31c | 1.84 ± 0.45d |
| CCl4 | 6.23 ± 0.51c | 1.35 ± 0.09a | 8.71 ± 1.12a | 15.75 ± 2.36a | 22.75 ± 2.36a |
| CCl4 + Sily 50 | 7.05 ± 0.14a | 1.03 ± 0.09c | 1.17 ± 0.46c | 2.84 ± 0.82c | 3.14 ± 0.78c |
| CCl4 + MBM 200 | 6.72 ± 0.17b | 1.21 ± 0.12b | 4.55 ± 0.93b | 5.31 ± 0.55b | 6.28 ± 1.62b |
| CCl4 + MBM 400 | 6.96 ± 0.15a | 1.08 ± 0.07c | 1.32 ± 0.41c | 2.26 ± 0.67d | 2.15 ± 0.45d |
| MBM 400 | 7.06 ± 0.16a | 1.03 ± 0.08c | 1.03 ± 0.31d | 2.63 ± 0.74c | 1.65 ± 0.42d |
Values are expressed as mean ± SE (06). Means ± SE with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d). MBM M. buxifolia methanol extract
Effect of M. buxifolia on biochemical markers of urine in rat
| Treatment mg/kg bw | Creatinine (mg/dl) | Urobilinogen (mg/dl) | Urea (mg/dl) | Albumin (mg/dl) | Protein (mg/dl) |
|---|---|---|---|---|---|
| Control | 1.94 ± 0.24d | 4.32 ± 0.48d | 101.26 ± 3.21d | 5.26 ± 0.44b | 37.87 ± 1.43d |
| CCl4 | 5.13 ± 0.75a | 33.25 ± 3.12a | 132.45 ± 3.12a | 19.37 ± 1.75a | 23.94 ± 1.39a |
| CCl4 + Sily 50 | 2.65 ± 0.34c | 11.25 ± 1.25c | 105.28 ± 3.46c | 7.22 ± 0.22 b | 34.77 ± 1.50c |
| CCl4 + MBM 200 | 3.22 ± 0.17b | 24.21 ± 1.62b | 114.55 ± 2.95b | 11.42 ± 0.44b | 26.53 ± 1.75b |
| CCl4 + MBM 400 | 2.14 ± 0.35c | 12.68 ± 0.87c | 106.22 ± 2.42c | 8.45 ± 0.45b | 34.62 ± 1.82c |
| MBM 400 | 2.06 ± 0.26d | 4.23 ± 0.65d | 103.24 ± 2.35cd | 6.22 ± 0.32b | 39.72 ± 1.91d |
Values are expressed as mean ± SE (06). Means ± SE with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d). MBM M. buxifolia methanol extract
Effect of M. buxifolia on biochemical markers of serum in rat
| Treatment mg/kg bw | Urobilinogen (mg/dl) | Urea (mg/dl) | Creatinine (mg/dl) | BUN (mg/dl) | Total bilirubin (mg/dl) | Albumin (mg/dl) | Protein (mg/dl) |
|---|---|---|---|---|---|---|---|
| Control | 14.57 ± 1.25d | 25.22 ± 1.29d | 0.61 ± 0.037d | 12.47 ± 0.85d | 3.12 ± 0.27c | 4.62 ± 0.26a | 8.24 ± 0.24a |
| CCl4 | 32.84 ± 1.53a | 75.65 ± 3.51a | 1.82 ± 0.455a | 35.74 ± 2.25a | 3.92 ± 0.35a | 2.67 ± 0.18c | 5.65 ± 0.21d |
| CCl4 + Sily 50 | 17.75 ± 1.61c | 29.95 ± 1.48c | 0.95 ± 0.039c | 16.85 ± 0.92c | 3.25 ± 0.39c | 3.45 ± 0.25b | 7.34 ± 0.32b |
| CCl4 + MBM 200 | 22.53 ± 1.42b | 39.64 ± 2.36b | 1.28 ± 0.352b | 22.29 ± 1.14b | 3.52 ± 0.38b | 3.62 ± 0.25b | 6.67 ± 0.25c |
| CCl4 + MBM 400 | 18.50 ± 0.84c | 28.23 ± 1.94c | 1.04 ± 0.022c | 15.40 ± 0.78c | 3.24 ± 0.32c | 4.45 ± 0.24a | 7.43 ± 0.35b |
| MBM 400 | 13.45 ± 0.62d | 26.25 ± 1.45cd | 0.66 ± 0.026d | 12.85 ± 0.94d | 3.16 ± 0.22c | 4.48 ± 0.23a | 8.28 ± 0.46a |
Values are expressed as mean ± SE (6). Means ± SE with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d). Sily silymarin, MBM M. buxifolia methanol extract
Effect of M. buxifolia on phase I antioxidant enzyme activities in renal tissues of rat
| Treatment mg/kg bw | Catalase (U/min) | POD (U/min) | SOD (U/mg protein) | QR (nM/min/mg protein) |
|---|---|---|---|---|
| Control | 5.58 ± 0.38a | 6.82 ± 0.46a | 5.36 ± 0.42a | 42.75 ± 2.03a |
| CCl4 | 2.13 ± 0.41c | 2.98 ± 0.43d | 1.23 ± 0.26d | 29.95 ± 1.08c |
| CCl4 + Sily 50 | 5.25 ± 0.33a | 5.82 ± 0.48b | 5.14 ± 0.23b | 39.34 ± 1.04a |
| CCl4 + MBM 200 | 3.77 ± 0.55b | 4.72 ± 0.39c | 2.92 ± 0.31c | 32.52 ± 1.13b |
| CCl4 + MBM 400 | 5.13 ± 0.62a | 5.92 ± 0.46b | 4.96 ± 0.54b | 39.73 ± 1.24a |
| MBM 400 | 5.79 ± 0.42a | 6.62 ± 0.36a | 5.48 ± 0.42a | 41.24 ± 1.28a |
Values are expressed as mean ± SE (6). Means ± SE with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d). MBM M. buxifolia methanol extract
Effect of M. buxifolia on phase II antioxidant enzyme activities in renal tissues of rat
| Treatment mg/kg bw | GST (nM/min/mg protein) | γ-GT (nM/min/mg protein) | GSH-Px (nM/min/mg protein) | GSR (μg/mg protein) |
|---|---|---|---|---|
| Control | 23.68 ± 1.25a | 312.32 ± 5.00a | 86.55 ± 2.29d | 141.64 ± 3.93d |
| CCl4 | 9.68 ± 0.95c | 87.54 ± 4.58d | 35.61 ± 1.78a | 62.55 ± 2.37a |
| CCl4 + Sily 50 | 22.65 ± 1.14a | 303.28 ± 5.25a | 84.33 ± 2.54d | 137.41 ± 3.65d |
| CCl4 + MBM 200 | 15.45 ± 0.85b | 264.42 ± 5.28c | 57.26 ± 1.39b | 101.39 ± 2.07b |
| CCl4 + MBM 400 | 21.73 ± 1.12 a | 306.24 ± 5.18a | 79.84 ± 2.33c | 132.22 ± 3.53c |
| MBM 400 | 21.62 ± 1.26a | 309.28 ± 5.23a | 88.53 ± 2.58d | 145.62 ± 3.84d |
Values are expressed as mean ± SE (6). Means ± SE with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d). MBM M. buxifolia methanol extract
Effect of M. buxifolia on biomolecules in renal tissues of rat
| Treatment mg/kg bw | GSH (μM/g tissue) | TBARS (nM/min/mg protein) | H2O2 (μM/ml) | Nitrite (μM/mg protein) | % DNA injuries |
|---|---|---|---|---|---|
| Control | 32.67 ± 1.22a | 3.18 ± 0.62c | 1.32 ± 0.27c | 105.42 ± 2.10c | 8.21 ± 0.53c |
| CCl4 | 15.30 ± 1.37d | 5.32 ± 0.55a | 2.72 ± 0.36a | 142.25 ± 2.24a | 26.32 ± 1.29a |
| CCl4 + Sily 50 | 31.21 ± 1.49b | 3.26 ± 0.12c | 1.45 ± 0.24c | 109.52 ± 2.12c | 9.15 ± 0.70c |
| CCl4 + MBM 200 | 23.64 ± 2.53c | 4.24 ± 0.39b | 2.04 ± 0.35b | 124.27 ± 2.41b | 14.23 ± 0.85b |
| CCl4 + MBM 400 | 30.57 ± 2.32b | 3.22 ± 0.35c | 1.38 ± 0.24c | 108.75 ± 2.12c | 9.49 ± 0.72c |
| MBM 400 | 34.46 ± 2.94a | 3.12 ± 0.31c | 1.43 ± 0.23c | 107.24 ± 2.35c | 8.02 ± 0.37c |
Values are expressed as mean ± SEM (06). Means ± SEM with different superscript letter (a–d) within the column indicate significant difference (P < 0.05 between a&b, P < 0.01 between a&c, P < 0.001 between a&d), MBM M. buxifolia methanol extract
Fig. 3Histopathology of renal tissues (40× magnification). a Control group; b CCl4 treated group; c CCl4 + Silymarin (50 mg/kg bw) treated group; d CCl4 + MBM (200 mg/kg bw) treated group; e CCl4 + MBM (400 mg/kg bw) treated group; f MBM (400 mg/kg bw) treated group. BC; Bowmans’ capsule, G; Glomerulus, PC; Proximal Convoluted Tubule, DC; Distal Convoluted Tubule, LI; Leukocytes Infiltration, LBB; Loss of Brush Border, DBC; Damaged Bowmans’ Capsule, DPC; Damaged Proximal Convoluted Tubule